SELLAS Life Sciences (SLS) Current Leases (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Current Leases for 9 consecutive years, with $576000.0 as the latest value for Q3 2024.
- Quarterly Current Leases rose 23.61% to $576000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $576000.0 through Sep 2024, up 23.61% year-over-year, with the annual reading at $446000.0 for FY2023, 19.89% up from the prior year.
- Current Leases for Q3 2024 was $576000.0 at SELLAS Life Sciences, up from $531000.0 in the prior quarter.
- The five-year high for Current Leases was $576000.0 in Q3 2024, with the low at $100000.0 in Q2 2020.
- Average Current Leases over 5 years is $318105.3, with a median of $341000.0 recorded in 2022.
- The sharpest move saw Current Leases tumbled 72.38% in 2020, then skyrocketed 87.88% in 2022.
- Over 5 years, Current Leases stood at $166000.0 in 2020, then grew by 19.28% to $198000.0 in 2021, then surged by 87.88% to $372000.0 in 2022, then grew by 19.89% to $446000.0 in 2023, then grew by 29.15% to $576000.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods came in at $576000.0, $531000.0, and $488000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.